| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |